van Amsterdam RG - Search Results

1

Biochemical and pharmacological properties of SANORG 32701. Comparison with the "synthetic pentasaccharide' (SR 90107/ORG 31540) and standard heparin.

Herbert JM, Hérault JP, Bernat A, van Amsterdam RG, Vogel GM, Lormeau JC, Petitou M, Meuleman DG. Herbert JM, et al. Among authors: van amsterdam rg. Circ Res. 1996 Sep;79(3):590-600. doi: 10.1161/01.res.79.3.590. Circ Res. 1996. PMID: 8781492

2

Biochemical and pharmacological properties of SANORG 34006, a potent and long-acting synthetic pentasaccharide.

Herbert JM, Hérault JP, Bernat A, van Amsterdam RG, Lormeau JC, Petitou M, van Boeckel C, Hoffmann P, Meuleman DG. Herbert JM, et al. Among authors: van amsterdam rg. Blood. 1998 Jun 1;91(11):4197-205. Blood. 1998. PMID: 9596667 Free article.

3

Experimental study of thrombogenicity and foreign body reaction induced by heparin-coated coronary stents.

De Scheerder I, Wang K, Wilczek K, Meuleman D, Van Amsterdam R, Vogel G, Piessens J, Van de Werf F. De Scheerder I, et al. Circulation. 1997 Mar 18;95(6):1549-53. doi: 10.1161/01.cir.95.6.1549. Circulation. 1997. PMID: 9118524

4

Synthetic analogues of the antithrombin III-binding pentasaccharide sequence of heparin. Prediction of in vivo residence times.

van Amsterdam RG, Vogel GM, Visser A, Kop WJ, Buiting MT, Meuleman DG. van Amsterdam RG, et al. Arterioscler Thromb Vasc Biol. 1995 Apr;15(4):495-503. doi: 10.1161/01.atv.15.4.495. Arterioscler Thromb Vasc Biol. 1995. PMID: 7749861

5

Pentasaccharide and Orgaran arrest, whereas heparin delays thrombus formation in a rat arteriovenous shunt.

Vogel GM, van Amsterdam RG, Kop WJ, Meuleman DG. Vogel GM, et al. Among authors: van amsterdam rg. Thromb Haemost. 1993 Jan 11;69(1):29-34. Thromb Haemost. 1993. PMID: 8446935

6

Pre-clinical pharmacological profile of the novel glycoconjugate Org 36764 with both factor Xa and thrombin (IIa) inhibitory activities.

Vogel GM, van Amsterdam RG, van Dinther TG, Tromp M, Meuleman DG. Vogel GM, et al. Among authors: van amsterdam rg. Thromb Haemost. 2000 Oct;84(4):611-20. Thromb Haemost. 2000. PMID: 11057859

7

Two new closely related rat models with relevance to arterial thrombosis--efficacies of different antithrombotic drugs.

Vogel GM, van Amsterdam RG, Zandberg P, van Houwelingen P, Kop WJ, van Mensvoort FW, Meuleman DG. Vogel GM, et al. Among authors: van amsterdam rg. Thromb Haemost. 1997 Jan;77(1):183-9. Thromb Haemost. 1997. PMID: 9031471

8

Feasible synthesis and biological properties of six 'non-glycosamino' glycan analogues of the antithrombin III binding heparin pentasaccharide.

Westerduin P, van Boeckel CA, Basten JE, Broekhoven MA, Lucas H, Rood A, van der Heijden H, van Amsterdam RG, van Dinther TG, Meuleman DG, et al. Westerduin P, et al. Among authors: van amsterdam rg. Bioorg Med Chem. 1994 Nov;2(11):1267-80. doi: 10.1016/s0968-0896(00)82078-7. Bioorg Med Chem. 1994. PMID: 7757423

9

Absence of an interaction between the synthetic pentasaccharide fondaparinux and oral warfarin.

Faaij RA, Burggraaf J, Schoemaker RC, Van Amsterdam RG, Cohen AF. Faaij RA, et al. Among authors: van amsterdam rg. Br J Clin Pharmacol. 2002 Sep;54(3):304-8. doi: 10.1046/j.1365-2125.2002.01616.x. Br J Clin Pharmacol. 2002. PMID: 12236851 Free PMC article. Clinical Trial.

10

Characterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma.

Nicholson CD, Shahid M, Bruin J, Barron E, Spiers I, de Boer J, van Amsterdam RG, Zaagsma J, Kelly JJ, Dent G, et al. Nicholson CD, et al. Among authors: van amsterdam rg. J Pharmacol Exp Ther. 1995 Aug;274(2):678-87. J Pharmacol Exp Ther. 1995. PMID: 7636728

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page